We are your trusted health partner. Local doorstep deliveries is within the hour .We are Licensed and Regulated by the Pharmacist's Council of Nigeria(PCN).Prices displayed here may differ due to inflation.
Abiraglob is a pharmaceutical-grade, systemic hormonal therapy designed for the clinical management of advanced prostate cancer. As a potent localized CYP17 inhibitor, it works by systemically blocking the production of androgens (male hormones) in the testes, adrenal glands, and the localized tumor itself. This provides a stable clinical tool to clear the path for slowing disease progression in the Nigerian medical environment.
Abiraglob is a pharmaceutical-grade, systemic hormonal therapy designed for the clinical management of advanced prostate cancer. As a potent localized CYP17 inhibitor, it works by systemically blocking the production of androgens (male hormones) in the testes, adrenal glands, and the localized tumor itself. This provides a stable clinical tool to clear the path for slowing disease progression in the Nigerian medical environment.
Active Ingredient: Abiraterone Acetate (250mg)
Drug Class: Anti-androgen; CYP17 Inhibitor
Formulation: Tablet
Route: Oral
Pack Size: 120 Tablets (Typical)
Availability: Prescription-Only Medicine (POM) — Strict specialist supervision required.
Globela Pharma — Produced under stringent systemic quality standards to ensure molecular stability and localized clinical efficacy in oncology care.
Abiraglob is primarily indicated for the systemic treatment of metastatic castration-resistant prostate cancer (mCRPC) and localized metastatic high-risk castration-sensitive prostate cancer (mHSPC). It is clinically used in combination with systemic Prednisolone to clear the path for reduced localized tumor growth and systemic relief of cancer-related symptoms. By lowering localized testosterone to nearly undetectable levels, it assists the body in maintaining stable clinical remission.
Prednisolone Combination: Abiraglob must be taken systemically with localized Prednisolone to clear the path for preventing localized mineralocorticoid excess and systemic clinical side effects.
Liver Toxicity: Systemic use can clear the path for localized liver inflammation. Regular clinical monitoring of systemic liver function tests (LFTs) is mandatory.
Cardiac Health: Use with localized caution in patients with a systemic history of localized heart failure, systemic hypertension, or localized electrolyte imbalances (like low potassium).
Fetal Risk: Though used in men, Abiraglob must not be handled by localized pregnant women as it can systemically clear the path for clinical harm to a developing male fetus.
The standard systemic dose is typically 1000mg (four 250mg tablets) taken once daily. To clear the path for systemic safety, Abiraglob must be taken on an empty stomach—at least 1 hour before or 2 hours after localized food. Swallow the tablets whole with a glass of water; do not crush or chew. Taking the systemic dose with localized food can clear the path for an unstable clinical increase in systemic drug absorption, leading to localized toxicity.
Commonly reported effects include localized joint swelling, systemic muscle aches, and localized hot flushes. Some patients may experience localized high blood pressure or systemic urinary tract infections. These are localized clinical signs of systemic hormonal changes. Consult your oncologist immediately if you experience localized yellowing of the eyes, systemic dark urine, or an unstable clinical heart rate.
Store below 30°C in a cool, dry place away from direct sunlight. In the Nigerian climate, localized heat can affect the systemic stability of oncological agents; ensure the localized bottle is tightly closed. Keep the medication in its original systemic container to preserve molecular integrity. Keep out of reach of children.
Q: Why must I take Prednisolone with Abiraglob? A: To clear the path for systemic safety; Prednisolone systemically replaces hormones that are localized and reduced during clinical treatment, preventing localized side effects like systemic fluid retention.
Q: Can I take Abiraglob with localized food? A: No. Systemic absorption is localized and highly sensitive to fat. Taking it with food clears the path for a dangerous systemic increase in clinical drug levels.
Q: How long should I systemically continue treatment? A: Treatment is typically localized and ongoing as long as the clinical benefit is systemically maintained and side effects remain localized and manageable.
Q: Is a prescription mandatory at Sanlive Pharmacy? A: Yes. Due to the need for systemic oncology monitoring and localized liver safety checks, a valid clinical prescription is mandatory.
Abiraglob 250mg Tablets are a Prescription-Only Medicine. A valid doctor's prescription is required. Our licensed pharmacists are available to provide guidance on localized oncology support and systemic safety.
Authentic Oncology Care: We guarantee 100% original Abiraglob with verified systemic purity and localized NAFDAC registration.
Potency Protection: Professional storage protocols to protect systemic molecular stability from the Nigerian heat.
Expert Support: Access to licensed pharmacists for guidance on managing localized dosing schedules and systemic safety.
Fast Delivery: Reliable and discreet shipping of essential oncology medications nationwide across Nigeria.
Order Abiraglob 250mg from Sanlive Pharmacy for advanced care and fast delivery.
No reviews yet — be the first!
Log in to write a review.
Welcome back! Sign in to continue.
Join Sanlive Pharmacy — fast, affordable healthcare delivery.
.jpg)
